Leber hereditary optic neuropathy: Bridging the translational gap
Current Opinion in Ophthalmology Sep 15, 2017
Jurkute N, et al. - Here, researchers address the clinical evolution of the disease, the secondary etiological factors that could contribute to the visual loss, and the challenging task of developing effective treatments. Leber hereditary optic neuropathy (LHON) is phenotypically more heterogeneous than previously considered and a complex interplay of genetic, environmental and hormonal factors modulates the risk of a LHON carrier losing vision. Advances in disease modelling, drug screening and genetic engineering offer promising avenues for therapeutic breakthroughs in LHON.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries